Incannex (IXHL) Healthcare announces the appointment of Douglas Kirsch, M.D., FAAN, FAASM to its IHL-42X Obstructive Sleep Apnea Clinical Advisory Board, CAB.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IXHL:
- Incannex Achieves Milestone in Sleep Apnea Drug Trial
- Incannex achieves milestone with database lock for RePOSE Phase 2 trial
- Incannex Healthcare Announces Psychedelic Therapies Joint Venture
- Incannex forms joint venture with Mind Medicine Australia
- Incannex Healthcare Transfers Listing to Nasdaq Capital Market